All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
Pentadecarginine
For educational and research purposes only. Not medical advice.
Pentadecarginine is an early-stage peptide with limited published research. Primarily studied in preclinical models for wound healing. Not yet well-characterized for dosing or safety in humans.
Best Time
Morning
Method
subcutaneous
Frequency
Daily
Half-life
~3 hours
Cycle Length
4-6 weeks
Storage
Refrigerate at 2-8°C.
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
Trial data for this peptide is being processed. Check back soon.
Mechanism of Action
Arginine-rich peptide that promotes nitric oxide production, enhances blood flow to injured tissues, and supports cellular repair through growth factor modulation.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.